Mutant Prevention Concentrations of ABT-492, Levofloxacin, Moxifloxacin, and Gatifloxacin against Three Common Respiratory Pathogens

The purpose of this study was to compare the mutant prevention concentration (MPC) of ABT-492 to those of levofloxacin, moxifloxacin, and gatifloxacin against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis. The fluoroquinolones had comparable mutation selection windows,...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Hermsen, Elizabeth D., Hovde, Laurie B., Konstantinides, George N., Rotschafer, John C.
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society for Microbiology 2005
Témata:
Susceptibility
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC1068586/
https://ncbi.nlm.nih.gov/pubmed/15793158
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.49.4.1633-1635.2005
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky